Analysis of Gastrointestinal Symptoms in 281 Cases of Hospitalized Covid 19 Patients, Single-Center Study
PDF
Cite
Share
Request
Clinical Research
VOLUME: 31 ISSUE: 3
P: 401 - 408
2021

Analysis of Gastrointestinal Symptoms in 281 Cases of Hospitalized Covid 19 Patients, Single-Center Study

Anatol J Gen Med Res 2021;31(3):401-408
1. Health Sciences University Tepecik Training and Research Hospital,Gastroenterology Izmir
2. Health Sciences University Tepecik Training and Research Hospital,Infectious Diseases,Izmir
3. Health Sciences University Tepecik Training and Research Hospital,Microbiology Laboratory, Izmir
4. Health Sciences University Tepecik Training and Research Hospital, Hematology, Izmir
5. Izmir Training and Research Hospital Hematology, Izmir
6. Health Sciences University Tepecik Training and Research Hospital, Biochemistry Laboratory, Izmir
No information available.
No information available
Received Date: 2021-08-10T13:24:07
Accepted Date: 2021-10-12T16:14:20
PDF
Cite
Share
Request

Abstract

Objective: Although Covid-19 which has been identified as the disease caused by SARS COV-2 virus mainly affects the respiratory tract, it was observed that many systems were affected. The gastrointestinal system is one of the main systems involved. The aim of this manuscript was to perform epidemiological, virological, and clinical analysis of 59 Covid 19-positive patients with gastrointestinal symptoms.

Method: Covid-19 diagnosed patients have been started to be admitted since March, 20, 2020. Epidemiological, demographical, clinical findings, laboratory analyses as well as hospitalization periods and disease progression of the patients presenting gastrointestinal system (GIS) symptoms admitted between March, 31, 2020 and August, 1, 2020.

Results: Totally 710 Covid 19-positive patients hospitalized were screened. Among these patients, those with incomplete medical history and deficient data were excluded. The analysis of 281 patients admitted due to Covid-19 diagnosis with complete data since admission revealed that 59 patients presented GIS symptoms at admission. The aforesaid patients were compared with 222 patients admitted due to Covid-19 without GIS symptoms within the same period. GIS symptoms were detected on 59 (59/281) (20.99%) patients admitted due to Covid-19. Detailed review of these patients revealed that 18 (18/59) (30.50%) patients had nausea-vomiting, 10 (10/59) (16.95%) patients had abdominal pain, and 31 (31/59) (52.55%) patients had GIS bleeding. It was observed that vomiting was added into the clinical presentation in 7 of 18 patients. Although there is not any diarrhea symptom alone, total number of cases with diarrhea+abdominal pain, diarrhea+nausea-vomiting, diarrhea+nausea-vomiting+abdominal pain was 17 (17/59) (28.81%) of 59 patients.

Conclusion: According to the results of this study, we have found 20.99% gi symptoms in the hospitalizated patients due to Covid 19. Although GIS symptoms are not associated with disease severity, they are important for the identification and spread of the disease, along with respiratory symptoms.

Keywords:
Covid 19, gastrointestinal symptoms, prognosis